Chris Lyle

VP Evidence Strategy

Greater Minneapolis-St. Paul Area

About

Experience

  • VP Evidence Strategy at DuVal & Associates, PA
    Jun 2024 - Present · 2 yrs 1 mo

  • JD LYMON Group (10 yrs 6 mos)
    • Partner
      Jan 2017 - Jun 2024 · 7 yrs 6 mos

    • Principal | Health Economics | Biostatistics
      2014 - Jun 2024 · 10 yrs 6 mos

      Provide strategic consulting in the areas of health economic analysis, clinical trial design, and evidence planning. Develop and negotiate study designs and statistical analysis plans with FDA. Work with my colleagues at JD LYMON Group to understand the reimbursement landscape new technologies will face and develop comprehensive market access solutions rooted in meaningful clinical evidence.

  • Senior Principal Advisor | VP Corporate Operations | VP Health Informatics & Market Access (select) at RCRI, Inc. (Regulatory & Clinical Research Institute, Inc.)
    2002 - 2014 · 12 yrs

  • Senior Biostatistician | Clinical Trial Design and Analysis, Data Management at 3M
    1997 - 2001 · 4 yrs